Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions

Anyone can find out if a submission has been accepted for review by Health Canada by searching the submissions under review list. We publish Regulatory Decision Summaries (RDS). These summaries explain the purpose of the submission and the reason(s) for Health Canada’s decision on certain health products seeking market authorization. You can access RDSs through the Drug and Health Product Register.

Données et ressources

Info additionnelle

Champ	Valeur
Dernière modification	avril 17, 2026, 17:30 (TU)
Créé le	avril 17, 2026, 17:30 (TU)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2018-08-14 00:00:00
open_canada_keywords	{"fr": ["Approche réglementaire du Canada", "médicaments contre les maladies rares", "recherche d'examens et de décisions sur les médicaments"], "en": ["Canada’s regulatory approach", "drugs for rare-diseases", "find drug reviews-and-decisions"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Médicaments utilisés pour soigner les maladies rares en Canada: rapports d’évaluation et des décisions sur les drogues
update_frequency	as_needed